Guidance for industry : CGMP for phase 1 investigational drugs.

Bibliographic Details
Corporate Authors:	Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.), United States. Food and Drug Administration. Office of Regulatory Affairs
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research : Office of Regulatory Affairs, [2008]
Subjects:	Drugs > Testing.
Online Access:	https://purl.fdlp.gov/GPO/LPS111655

Description
Item Description:	Title from PDF title page (viewed on Apr. 21, 2009). "July 2008." Electronic resource.
Physical Description:	17 pages : digital, PDF file.
Format:	Mode of access: Internet at the FDA CBER Web site. Address as of 4/21/09: http://www.fda.gov/cber/gdlns/indcgmp.pdf ; current access is available via PURL.
Bibliography:	Includes bibliographical references (page 17).